Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
04/2007
04/26/2007US20070092941 PRO1298 polypeptides
04/26/2007US20070092534 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
04/26/2007US20070090104 Microwave-Assisted Peptide Synthesis
04/25/2007EP1777231A2 Process of purication of LH and recominant hLH purified by that method
04/25/2007EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders
04/25/2007EP1776389A2 Sialic acid derivatives
04/25/2007EP1776382A1 A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures
04/25/2007EP1776379A1 Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions
04/25/2007EP1560939A4 Immobilization of biological molecules onto surfaces coated with monolayers
04/25/2007EP1476463B1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
04/25/2007EP1358000B1 Apparatus and method for separation of molecules and movement of fluids by electrophoresis
04/25/2007EP1334116B1 A process of producing polyphenolic adhesive proteins
04/25/2007EP1196637B1 Peptide acceptor ligation methods
04/25/2007CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies
04/25/2007CN1312179C Method for modifying freshwater fish skin collagen by adjusting alkalinity acidity
04/25/2007CN1312176C Buthotoxin polypeptide and preparation method thereof
04/25/2007CN1312172C Use of tissue fibre proteinogen
04/25/2007CN1312171C DNA vaccines encoding HIV accessory proteins
04/24/2007US7208585 Using hydrophobic charge induction chromatography to isolate preferential immunoglobulins in mixture; rationally designed liquid chromatography
04/24/2007US7208576 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
04/24/2007US7208574 Host receptor for pathogenic bacteria
04/24/2007US7208573 Enrichment of phosphate peptides for proteomic analysis
04/24/2007US7208532 Providing starting support matrix that has pendent unsaturated groups, subjecting matrix to electron beam or gamma-ray irradiation for the production of a cross-linked support matrix in form of a porous monolith or particles
04/24/2007US7208471 Glycopeptide phosphonate derivatives
04/24/2007US7208299 Controlling adhesion of cells to hydrophobic surfaces using biomolecule conjugated end group activated polymer
04/24/2007US7208293 Directed evolution of novel binding proteins
04/24/2007US7208279 Method for identifying inhibitors of G protein coupled receptor signaling
04/24/2007US7208270 Detecting demyelinating nervous system disorder by measurement of stem cell factor (SCF)-apoptosis-response gene protein(SARG-1-) protein; antiproliferative agents; microtubule associated protein 1(map1a); cancer screening
04/24/2007CA2188654C Modified milk growth factor
04/24/2007CA2188093C Process for purifying factor vii and activated factor vii
04/19/2007WO2007043834A1 Method for inducing the expression of structurally mismatched protein in cell membrane by intracellular alkalization
04/19/2007WO2007043615A1 Peptide ester reagent, and use thereof for ligation or production of thioester compound
04/19/2007WO2007041775A1 Cysteine protease inhibitors incorporating azide groups
04/19/2007WO2006134390A3 Method for diagnosing neurodegenerative disease
04/19/2007WO2006134174A3 Dimeric and multimeric fviia compound
04/19/2007WO2006099481A3 Macromolecules comprising a thioether cross-link
04/19/2007WO2006047451A3 Immunoassays for lamotrigine
04/19/2007WO2004099375A3 Indirectly linked photosensitizer immunoconjugates, processes for the production thereof and methods of use therof
04/19/2007US20070087404 Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same
04/19/2007US20070084727 Coherent nonlinear chromatography and methods and devices thereof
04/19/2007DE102006001773B3 Preparation of a molded protein composite comprises dispersing the protein in water and in aqueous solution of ionic liquid, applying the solution on a smooth plate and recovering the molded protein composite as foil/membrane
04/19/2007CA2625349A1 Methods and compositions relating to anthrax spore glycoproteins as vaccines
04/19/2007CA2624802A1 Latent procytotoxins and uses thereof
04/18/2007EP1775000A2 Method of producing universal blood plasma from blood
04/18/2007EP1774331A2 Cytoxan antibodies and immunoassay
04/18/2007EP1773980A2 Method for assaying for natural killer, cytotoxic t- lymphocyte and neutrophil-mediated killing of target cells using real-time microelectronic cell sensing technology
04/18/2007EP1773866A1 Use of metal complexes
04/18/2007EP1773865A1 Use of magnetic material to fractionate samples
04/18/2007EP1773864A1 Silk peptide improving neuroprotective and neurofunctional effects and a method of its preparation
04/18/2007EP1773863A2 Method for purifying a protein of the cystine-knot superfamily
04/18/2007EP1773388A2 Sars vaccines and methods to produce highly potent antibodies
04/18/2007EP1606232A4 Improved extraction process
04/18/2007EP1575990A4 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis
04/18/2007EP1567862A4 Compositions and methods for the reversible capture of biomolecules
04/18/2007EP1476188B1 Method for accessing microbial diversity
04/18/2007EP1349569B1 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
04/18/2007EP1090036B1 Site specific protein modification by mutagenesis
04/18/2007EP0799242B1 Amphiphilic complexes, method for preparing same and compositions containing such complexes
04/18/2007CN1948497A High activity, low antigen glucokinase derivant and preparation method
04/18/2007CN1948496A Low antigen recombination glucokinase mutant and its preparation method
04/18/2007CN1948339A Preparation and purification of telomerase activity inhibition protein
04/18/2007CN1948337A Preparation method of wheat germ agglutinin and its application in inhibiting mammary gland cancer activity
04/18/2007CN1311076C Method for producing recombinaton urokinase
04/18/2007CN1310893C Condensation reagent and its preparation method
04/17/2007US7205393 Process for the isolation and purification of a glycoprotein Avidin
04/17/2007US7205385 Polymerization method for the synthesis of polypeptide imaging agents
04/17/2007US7205382 Solid phase synthesis; for autoimmune diseases, rheumatoid diseases, multiple sclerosis, and myasthenia gravis
04/17/2007US7205278 Introducing one or more cysteine residues into a polypeptide which permit the stabilization of the polypeptide by formation of at least one bond, preferably a disulfide bond, between different domains of the polypeptide.
04/17/2007US7205144 Nucleotide sequences encoding a sensor kinase, citA, from Corynebacterium glutamicum
04/17/2007US7205131 Process for the preparation of L-amino acids via overexpression of the PTSH gene
04/17/2007US7205116 5-Fluoro-uracil immunoassay
04/17/2007US7204991 Porphyromonas gingivalis recombinant proteins and truncations
04/17/2007US7204972 Annexin derivatives with endogenous chelation sites
04/17/2007CA2269589C A solid-phase technology for the preparation of amides
04/17/2007CA2211314C A process for preparing certain aza cyclohexapeptides
04/17/2007CA2174648C Apparatus and method for polymer synthesis using arrays
04/17/2007CA2162193C Lactoferrin receptor protein
04/17/2007CA2133205C Stable polypeptide composition
04/17/2007CA2100690C Megakaryocyte differentiation factor
04/12/2007WO2007040212A1 Neuronal differentiation inhibitor peptide and use thereof
04/12/2007WO2007039231A2 Method of producing a modified (poly)peptide
04/12/2007WO2007012605A3 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof
04/12/2007WO2007005491B1 Hydrazide conjugates as imaging agents
04/12/2007WO2007000525A3 Method for obtaining an exfoliating cosmetic active ingredient, active ingredient obtained, and associated compositions
04/12/2007WO2006128455A3 Compounds modifying apoptosis
04/12/2007WO2006015387A3 Method for assaying cytolytic activity of target cells
04/12/2007US20070082401 Method of preparing solution having composition of biological components
04/12/2007US20070082378 a ligation involves reacting a peptide having a protected cysteyl group at its N-terminal and a phenylthioester at its C-terminal with a second peptide having a cysteine residue at its N-termini and a thioester at its C-termini to form a ligation product; deprotection; selectively desulfurization
04/12/2007US20070082004 Method for removing a proteinaceous component from a liquid-phase surfactant preparation
04/12/2007US20070081922 Reactor for solid phase synthesis
04/12/2007US20070080316 Porous ferro- or ferrimagnetic glass particles for isolating molecules
04/12/2007US20070080063 Microfluidic sample delivery devices, systems, and methods
04/12/2007US20070080062 Coated metal structures and methods of making and using thereof
04/12/2007DE102005046657A1 Stationäres Trennsystem für Gemischkomponenten Stationary separation system for mixture components
04/12/2007CA2854550A1 Av.beta.6 peptide ligands and their uses
04/12/2007CA2624467A1 Method of treating pancreatitis
04/12/2007CA2624155A1 Method of producing a modified (poly)peptide
04/11/2007EP1771731A2 Detection of truncation mutations by mass spectrometry
04/11/2007EP1771463A1 Method of peptide synthesis
04/11/2007EP1592476B1 Methods for the purification of stable radioiodine conjugates